UBS analyst Kevin Caliendo raised the firm’s price target on Solventum (SOLV) to $82 from $79 and keeps a Neutral rating on the shares. The firm updated its model following the Q4 earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum Earnings Call Balances Growth With Headwinds
- Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks
- Solventum price target raised to $99 from $97 at KeyBanc
- Solventum sees 2026 adjusted EPS $6.40-$6.60, consensus $6.34
- Solventum reports Q4 adjusted EPS $1.57, consensus $1.50